CBK289001 is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of novel therapeutic agents, particularly in the area of oncology. Researchers leverage its unique chemical structure to design and develop compounds that target specific cancer pathways, aiming to improve the efficacy and selectivity of cancer treatments. Additionally, CBK289001 is explored in the study of enzyme inhibition, where it helps in understanding the mechanisms of action of various enzymes involved in disease progression. Its application extends to drug discovery programs, where it is used to optimize the pharmacokinetic and pharmacodynamic properties of potential drug candidates.